Anti-SARS-CoV-2 Antibody
COVID-19 Antigen Detection
CommercialDeveloped for lateral flow/rapid tests
Key Facts
Indication
COVID-19 Antigen Detection
Phase
Commercial
Status
Developed for lateral flow/rapid tests
Company
About Bioventix
Bioventix is a leading developer of high-affinity sheep monoclonal antibodies, primarily serving the global in vitro diagnostics (IVD) market. Its core expertise lies in creating antibodies for demanding diagnostic assays, with its anti-vitamin D antibody, VITROS® Immunodiagnostic Products 25-OH Vitamin D Total assay, being a major commercial success licensed to Ortho Clinical Diagnostics. The company operates a capital-light, high-margin business model focused on R&D, licensing, and royalty generation from its antibody intellectual property.
View full company profile